Sanj K. Patel - 02 Sep 2023 Form 4 Insider Report for Kiniksa Pharmaceuticals, Ltd. (KNSA)

Role
CHAIRMAN & CEO, Director
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
Issuer symbol
KNSA
Transactions as of
02 Sep 2023
Net transactions value
-$117,553
Form type
4
Filing time
06 Sep 2023, 19:06:42 UTC
Previous filing
11 Apr 2023
Next filing
06 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KNSA Class A Common Share Options Exercise +9,992 +23% 52,566 01 Sep 2023 Direct F1
transaction KNSA Class A Common Share Tax liability $78,712 -4,432 -8.4% $17.76 48,134 01 Sep 2023 Direct
transaction KNSA Class A Common Share Options Exercise +6,569 +14% 54,703 02 Sep 2023 Direct F1
transaction KNSA Class A Common Share Tax liability $38,841 -2,187 -4% $17.76 52,516 02 Sep 2023 Direct
holding KNSA Class A Common Share 83,336 02 Sep 2023 Held by The Anglia 2013 Revocable Trust, u/d/t August 15, 2013
holding KNSA Class A Common Share 109,795 02 Sep 2023 Held by The Marina 2016 Irrevocable Trust, u/d/t June 23, 2016

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KNSA Restricted Share Unit Options Exercise $0 -9,992 -25% $0.000000 29,975 01 Sep 2023 Class A Common Share 9,992 Direct F1, F2
transaction KNSA Restricted Share Unit Award $0 +25,925 $0.000000 25,925 01 Sep 2023 Class A Common Share 25,925 Direct F1, F3
transaction KNSA Share Option Award $0 +155,500 $0.000000 155,500 01 Sep 2023 Class A Common Share 155,500 $17.76 Direct F4
transaction KNSA Restricted Share Unit Options Exercise $0 -6,569 -33% $0.000000 13,138 02 Sep 2023 Class A Common Share 6,569 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.
F2 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 1, 2022.
F3 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 1, 2023.
F4 The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2023.
F5 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 2, 2021.